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ABSTRACT
The Pancreatic Expression Database (PED, http://
www.pancreasexpression.org) is the only device
currently available for mining of pancreatic cancer
literature data. It brings together the largest collec-
tion of multidimensional pancreatic data from the lit-
erature including genomic, proteomic, microRNA,
methylomic and transcriptomic profiles. PED allows
the user to ask specific questions on the observed
levels of deregulation among a broad range of
specimen/experimental types including healthy/
patient tissue and body fluid specimens, cell lines
and murine models as well as related treatments/
drugs data. Here we provide an update to PED,
which has been previously featured in the Database
issue of this journal. Briefly, PED data content has
been substantially increased and expanded to
cover methylomics studies. We introduced an exten-
sive controlled vocabulary that records specific
details on the samples and added data from large-
scale meta-analysis studies. The web interface has
been improved/redesigned with a quick search
option to rapidly extract information about a gene/
protein of interest and an upload option allowing
users to add their own data to PED. We added a
user guide and implemented integrated graphical
tools to overlay and visualize retrieved information.
Interoperability with biomart-compatible data sets
was significantly improved to allow integrative
queries with pancreatic cancer data.
INTRODUCTION
Pancreatic cancer is almost invariably lethal and remains
one of the most devastating human malignancies (1). A
multitude of studies have been dedicated to elucidating its
pathogenesis, resulting in the generation of an increasing
volume of data. Hence, there is no shortage of pancreatic
cancer raw data but an urgent need for bioinformatics
tools to allow robust and rigorous data mining, integra-
tion and analysis.
The pancreatic expression database (PED) (2,3) over-
comes these challenges and allows the international com-
munity to assess and exploit the high volume of pancreatic
cancer data to maximal advantage. Here, we provide an
update to PED, describing its increased data content and
several new structural, design and visualization enhance-
ments from PED 2.0 reported in 2011 (3) to the current
PED 3.0 release. These updates further expand the utility
of PED for pancreatic cancer research.
NEW DEVELOPMENTS
Improved data structure, content and connectivity
Many new data sets were added to PED (Figure 1).
Currently, PED 3.0 holds 153 data sets comprising
>250 000 expression/genomic measurements, which is
four times larger than the previous release. PED 3.0
database structure and existing content underwent major
revisions. We have introduced an extensive controlled vo-
cabulary and expanded the data content to cover differ-
ential methylomics alongside transcriptomic, proteomic,
microRNA (miRNA) and genomic studies. We have
expanded PED connectivity with external databases. We
also have added data from large-scale meta-analysis
studies and included an option allowing users to add
their own data to PED. A detailed comparison between
features of PED 2.0 and 3.0 is presented in Table 1.
Data structure
Similar to the previous release, PED data are divided into
two separate data sets. The ‘Gene Expression Data Set’
contains relevant data from transcriptomic, proteomic,
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Table 1. Summary of PED features
Features PED 2.0 PED 3.0
DATA SETS
Internal Pancreatic gene expression
Pancreatic copy number alterations
External
ICGC  ICGC
NCBI  NCBI
Reactome  Reactome
+ COSMIC
+UniProt
+ InterPro
+ PRIDE
STUDIES Type (number)
Transcriptomics (34)  Transcriptomics (47)
Proteomics (15)  Proteomics (32)
miRNA (6)  miRNA (12)
Genomics (4)  Genomics (6)
+Methylomics (4)
+Meta Analysis
+ Transcriptomics (2)
+ Proteomics (1)
ANNOTATIONS Ensembl Mart Release 56  Release 63
OUTPUT
Presentation HTML, TSV, CSV
Download archive HTML, TSV, CSV, XLS
Graphical visualization
+ Integrated Expression, Methylation and genomic view
+UCSC genome browser
+ CIRCOS whole genome view
OTHER
Query interface
PED MartView  Enhanced ﬁlters/attributes selection in PED MartView
+Quick search
+ Expression Landscape
Data upload
PED team  PED team
+User upload form
Help section
Step by Step Instructions
(FAQ in HTML)
+ Step by Step Instructions (FAQ in video presentation)
+ User guide (HTML)
 Updates to existing features
+ New features in current release
Figure 1. Data growth in PED. Data for the three releases are shown.
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methylomic and miRNA studies, and the ‘Copy Number
Alteration Data Set’ contains copy number alteration
(CNA) data from genomic studies.
The underlying structures of these data sets have
changed signiﬁcantly to accommodate detailed informa-
tion on the experimental design and presentation. Each
data set is now conceptually divided into three separate
parts:
(i) STUDY: contains basic information about the
published articles.
(ii) EXPERIMENT: contains detailed information
about the experimental design. It uses an extensive
controlled vocabulary to record speciﬁc details of
the samples used in each study including experiment
focus, platform technology, types of target and
baseline samples, computational pipeline, etc. One
study may correspond to multiple experiments.
(iii) EXPRESSION (CNA): contains lists of genes/
proteins/probesets/miRNAs (genomic regions)
reported to be expressed/regulated (altered) in the
speciﬁc experiments. Depending on the availability
of data in the published article, we also store add-
itional information such as fold-change, P-value,
expression site (copy-number, log2ratio, frequency)
and validation method.
Data from the original articles are manually curated,
reviewed for accuracy and consistency and loaded into
PED. The gene expression data set is built around the
Ensembl human gene annotations (4), which enables
direct integration of heterogeneous pancreatic-related
data with a rich collection of public annotations such as
genes, proteins, Single Nucleotide Polymorphism (SNP)
information, sequences, gene structures and multi-species
data. To avoid annotation errors, all data are mapped at
the transcript level using the pre-established Ensembl an-
notations and microarray probe set mapping (Ensembl
release 63). Where possible, obsolete or discontinued
probe identiﬁers are mapped to current identiﬁers. All
CNA data are presented on the GRCh37/hg19 genome
version. Genomic data conversions between assemblies
are done, where necessary, using the LiftOver tool from
the UCSC Genome Browser (5).
Data content
In the latest version, PED 3.0 represents pancreatic-
centred data extracted from 99 published studies repre-
senting 153 experimental data sets. The database
contains 226 135 differential or expression measurements
and 63 894 DNA CNAs on a large number of specimen
types, including pancreatic tissues and body ﬂuids col-
lected from healthy subjects and patients with benign, pre-
cancerous and malignant disease states, pancreatic cancer
cell lines and xenograft models under different treatment
conditions. This is over four times larger than the previous
version (Figure 1).
In addition to the transcriptomic, proteomic, miRNA
and genomic data, the data collection pipeline has been
enhanced to cover differential methylomic and large-scale
meta-analysis studies. Altogether, the PED 3.0 data
collection now describes pancreatic disease expression
measurements and related-regulation events in 11 992
genes/proteins, 56 878 transcripts and 428 miRNAs as
well as methylation events in 2440 genes and 15 072 tran-
scripts. The CNA section includes information on 32 039
gains, 23 991 losses, 1053 deletions, 4719 ampliﬁcations
and 125 Loss of Heterozygosity events occurring in
distinct genes and genomic areas.
Data upload
Until now, our team selected the data sets for inclusion
in PED. In responding to a long-standing request
from our users’ community, we have added an upload
function for researchers to upload their own published
data sets to be included in PED. To encourage participa-
tion, the submission process is kept simple; no registra-
tion nor login requirement is imposed, although
users need to provide a valid email address so that we
can contact them in case there are issues/questions regard-
ing the uploaded data set. Our team will check the
submitted data and perform necessary modiﬁcations or
additions required for the inclusion of the uploaded data
into PED.
Data connectivity and interoperability
In addition to NCBI (6), we also provide direct access to a
number of BioMart-compatible data sets available
through BioMart interface (7,8) such as ICGC (9,10),
Reactome (11), COSMIC (12), UniProt (13), PRIDE
(14) and InterPro (15) to allow integrative queries with
PED data sets. This integration allows researchers to
quickly extract related information about pancreatic
cancer genes and genomic regions such as the pathways
they control, overlapping somatic mutations, functional
analysis of the resulting proteins or a broad range of
proteomics data.
Improved query and data retrieval
Filter and attribute selection
The basic PED request-response architecture through our
customized version of MartView remains the same.
However, with our enriched data content, the interface
has been greatly improved with an enhanced structure
for ﬁlters and attributes to accommodate elaborate yet
precise queries. This greatly improves and facilitates
data navigation and retrieval across the experimental
data sets. Independent experimental validation of micro-
array experiments is presented, where available.
The specimen/sample information has been signiﬁcantly
improved and reﬁned. An extensive controlled vocabulary
is used to record ﬁne-grained details of the samples used in
each experiment. This provides users with more control
over the selection of experimental data types. For two-
group (differential expression) studies, specimen/sample
information is segregated into a target group and a
baseline/control group to better reﬂect the experimental
designs. This offers a better representation and facilitates
the query of cancer specimens versus normal control, or
specimens that are treated versus non-treated. A compre-
hensive list of changes in ﬁlters and attributes presentation
from PED 2.0 to this current release 3.0 is provided as
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Figure 2. Integrated graphical view of transcriptomic and genomic changes observed between pancreatic ductal adenocarcinoma and normal tissue
samples. This query starts by choosing the ‘Pancreatic Expression Database’ from the ‘Choose Database’ from the drop-down selection in the right
panel. A ‘Choose Dataset’ drop-down selection menu will automatically appear. In this example, users will choose ‘Pancreatic Gene Expression’ data
set. The next step involves choosing the appropriate ﬁlters to restrict the query in this ﬁrst data set by clicking on the ‘Filters’ node on the left,
expanding the ﬁlter section ‘EXPERIMENT:’, selecting ‘PDAC study—tissue’ and ‘Pancreatic ductal adenocarcinoma (PDAC)/Normal pancreas
(NP)’. The overlapping CNAs are added as a second data set by clicking on the second ‘Dataset’ from the bottom of the left panel and choosing
‘Pancreatic Copy Number Alteration’ from the ‘Choose additional dataset’ drop down menu that will appear in the right panel. Clicking the ‘Results’
button on the left side of the toolbar will retrieve a result table. To generate the graphical view of the results, simply hit the UCSC or CIRCOS
buttons on the right side of the toolbar. (A) Single chromosome (chr 1) view in UCSC Genome Browser. (B) Whole-genome view in CIRCOS viewer.
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Supplementary Material (Supplementary Table S1,
Supplementary Table S2).
Quick search
The home page offers the option to quickly extract
summarized information about a gene/protein of interest
using HGNC/Ensembl gene, miRNA accession or
SwissProt/Ensembl protein identiﬁers. The search box
has an autocomplete function. As users type, it will try
to complete the search term by suggesting possible
matching terms. The results contain a summary of the
studies reporting a link between the search term and pan-
creatic cancer. The retrieved information includes study
type, experimental questions, platform technology, target
and baseline samples used, observations/ﬁndings, corres-
ponding fold-change and P-value as well as validation
method (if any). This allows users to quickly validate or
check the current knowledge about the role of a gene/
protein in pancreatic cancer.
Graphical visualization
We have implemented integrated graphical tools to PED
MartView to allow users to query, overlay and visualize
retrieved information using UCSC Genome Browser (5)
and CIRCOS viewer (16). Based on the selection criteria, a
separate browser window displays differentially expressed
genes and/or CNA regions in the UCSC genome browser
under different tracks (Figure 2A). Users can choose to
change the chromosomal view by selecting a chromosome
from the drop-down list provided. A simple color-coding
scheme is used to present up/down-regulated genes and
different types of CNAs. Users can also opt for a
whole genome view generated by the CIRCOS software
(Figure 2B). To provide additional ﬂexibility, users can
click on a particular chromosomal band in the static
image to be redirected to the UCSC Genome Browser
for a detailed view of the region of interest.
Improved website and documentation
We have completely redesigned the web interface and
improved its functionality by using modern web
technologies. The website home page now contains a
quick search option for users to quickly investigate the
relationship between their gene/protein of interest and
pancreatic cancer. In addition to the updated ﬁlter and
attribute grouping, the PED Mart query interface has
been reconﬁgured with additional visualization options.
Another query interface has been created for interested
users to view the published results from the largest
meta-analysis on the pancreatic cancer expression land-
scape (17). An extensive user guide has been added to
describe all the features and functionalities of the
website. Additionally, FAQs have been added with short
video presentations. A glossary section has been included
in the user guide to describe the ﬁlter and attribute groups
speciﬁc to PED. For users who may not be familiar with
the abbreviations used for different experimental features,
an explanatory list of acronyms is also provided.
FUTURE DIRECTIONS
The amount of pancreatic cancer data is growing continu-
ously. Though PED provides a good coverage of the
cancer-related changes in the human model, there is a
considerable amount of experimentally derived informa-
tion available in the pancreatic cancer mouse model as
well as in single gene studies that need to be integrated
and made easily accessible. New ﬁndings are also being
discovered from next-generation sequencing. Thus, imple-
menting new modules to handle these new data types will
be our next target. We also plan to further develop the
analytical aspect of PED to allow comparative analysis of
alterations in human tissues, cell lines and mouse models
as well as survival analysis and basic data processing. An
ultimate goal is to integrate and present all levels of details
from single-gene studies and therapeutic information.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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